Showing results (21-30 of 199) with videos related to
Sort By:
Pageof 20
Cancer Cell|August 16, 2017
A Viro-Immunotherapy Triple Play for the Treatment of GlioblastomaJohn C Bell, Carolina S IlkowMolecular Therapy : the Journal of the American Society of Gene Therapy|February 1, 2007
Cell-based delivery of oncolytic viruses: a new strategic alliance for a biological strike against cancerAnthony T Power, John C BellImmunology and Cell Biology|February 23, 2011
A critical role for IL-15 in TLR-mediated innate antiviral immunity against genital HSV-2 infectionAmit Thatte, Stephanie J DeWitte-Orr, Brian Lichty, et al.Current Opinion in Molecular Therapeutics|January 27, 2009
Diplomatic immunity: turning a foe into an allyKelley A Parato, Brian D Lichty, John C BellEbiomedicine|July 14, 2016
Oncolytic Viruses: Therapeutics With an Identity CrisisCaroline J Breitbach, Brian D Lichty, John C BellTrends in Cancer|July 26, 2017
Oncolytic Viruses: Exploiting Cancer's Deal with the DevilLarissa A Pikor, John C Bell, Jean-Simon DialloStem Cells (Dayton, Ohio)|March 16, 2019
Concise Review: Targeting Cancer Stem Cells and Their Supporting Niche Using Oncolytic VirusesMathieu J F Crupi, John C Bell, Ragunath SingaraveluNature Biotechnology|July 12, 2012
Oncolytic virotherapyStephen J Russell, Kah-Whye Peng, John C BellJournal of Virology|April 18, 2008
Vesicular stomatitis virus oncolysis of T lymphocytes requires cell cycle entry and translation initiationStephanie Oliere, Meztli Arguello, Thibault Mesplede, et al.The Journal of General Virology|October 13, 2006
Matrix protein of Vesicular stomatitis virus harbours a cryptic mitochondrial-targeting motifBrian D Lichty, Heidi McBride, Stephen Hanson, et al.Pageof 20